PiB
Sponsors
Washington University School Of Medicine, NYU Langone Health
Conditions
Alzheimer DiseaseDominantly Inherited Alzheimer Disease (DIAD)Dominantly Inherited Alzheimer’s Disease (DIAD)
Phase 2
A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer’s Disease (DIAD)
Active, not recruitingCTIS2024-515198-91-00
Start: 2022-12-20Target: 24Updated: 2025-07-04
A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled, Two-Stage Adaptive Design, Platform Trial of Investigational Treatments for Primary Prevention of Disease Progression in Dominantly Inherited Alzheimer’s Disease
Not yet recruitingCTIS2024-517187-36-01
Target: 27Updated: 2025-10-20